Outcome
In this study we compare a combination of oseltamivir with routine regimen (oselta group), with routine regimen alone as a control group (control group), to evaluate the efficacy of oseltamivir in the treatment and outcome of Covid-19 infected patients.
The primary endpoint was the duration of hospitalization (length of hospital stay). The secondary endpoints were, requirement to admission to the intensive care unit (ICU), mechanical ventilation, and patient’s outcome discharge or mortality.